These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15988137)

  • 21. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
    Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dosage statins reduce choroidal damage in hypercholesterolemic rabbits.
    Rojas B; Ramírez AI; Salazar JJ; de Hoz R; Redondo A; Raposo R; Mendez T; Tejerina T; Triviño A; Ramírez JM
    Acta Ophthalmol; 2011 Nov; 89(7):660-9. PubMed ID: 20064114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct free radical scavenging effects of water-soluble HMG-CoA reductase inhibitors.
    Umeda R; Takanari H; Ogata K; Matsumoto S; Kitano T; Ono K; Tokumaru O
    J Clin Biochem Nutr; 2019 Jan; 64(1):20-26. PubMed ID: 30705508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superoxide anion scavenging properties of fluvastatin and its metabolites.
    Suzumura K; Yasuhara M; Narita H
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1477-80. PubMed ID: 10553644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters.
    Suzumura K; Ohashi N; Oka K; Yasuhara M; Narita H
    Free Radic Res; 2001 Dec; 35(6):815-23. PubMed ID: 11811532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of two HMG-CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography-tandem mass spectrometry for pharmaceutical study.
    Deng JW; Kim KB; Song IS; Shon JH; Zhou HH; Liu KH; Shin JG
    Biomed Chromatogr; 2008 Feb; 22(2):131-5. PubMed ID: 17703482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants.
    Mukai Y; Narita M; Akiyama E; Ohashi K; Horiuchi Y; Kato Y; Toda T; Rane A; Inotsume N
    Biol Pharm Bull; 2017; 40(7):1078-1085. PubMed ID: 28674251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis.
    Imaeda A; Aoki T; Kondo Y; Hori M; Ogata M; Obayashi H; Hasegawa G; Nakamura N; Tokuda K; Nishino H; Yoshikawa T; Kondo M
    Free Radic Res; 2001 Jan; 34(1):33-44. PubMed ID: 11234994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
    Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
    J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Woman Experienced Severe Thrombocytopenia When Treated With Fluvastatin].
    Potier A; Dony A; Crapsky A; Ferry O; Piney D; Dufay E
    Therapie; 2015; 70(6):541-4. PubMed ID: 26238127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of chlorpromazine, bleomycin and WR-2721 singly or in combination on the formation of radiation-induced micronuclei in mice bone marrow.
    Jagetia GC
    Strahlenther Onkol; 1994 Nov; 170(11):648-53. PubMed ID: 7526477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
    Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
    Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
    Plosker GL; Wagstaff AJ
    Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
    Ongini E; Impagnatiello F; Bonazzi A; Guzzetta M; Govoni M; Monopoli A; Del Soldato P; Ignarro LJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8497-502. PubMed ID: 15173604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managed care trends in statin usage.
    Bazalo GR
    Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenicity and mutagenicity studies with fluvastatin, a new, entirely synthetic HMG-CoA reductase inhibitor.
    Robison RL; Suter W; Cox RH
    Fundam Appl Toxicol; 1994 Jul; 23(1):9-20. PubMed ID: 7958569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on copper-induced hydroxyl radical generation in the rat heart.
    Obata T
    Toxicology; 2006 Jun; 223(3):175-80. PubMed ID: 16647179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.